Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020


Phacilitate Leaders Europe Agenda


Closing Panel Discussions: Discussing lessons learned since first submissions - what processes are now best practices?

17 Sep 2019
Manufacturing & Commercialisation
Pascale Belguise, Director of Business Development - Polyplus-transfection
Christopher Bravery, Director - CAB Consulting
Dana Fuchs-Telem, Director of Project Management - ATVIO Biotech Ltd
Christoph Prinz, Head of Quality Management and Qualified Person - apceth Biopharma GmbH
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd